Loading…

Neonatal screening for severe combined immunodeficiency in Brazil

Objective: To apply, in Brazil, the T‐cell receptor excision circles (TRECs) quantification technique using real‐time PCR in newborn screening for severe combined immunodeficiency (SCID) and assess the feasibility of implementing it on a large scale in Brazil. Methods: 8715 newborn blood samples wer...

Full description

Saved in:
Bibliographic Details
Published in:Jornal de Pediatria (Versão em Português) 2016-07, Vol.92 (4), p.374-380
Main Authors: Marilia Pyles Patto Kanegae, Lucila Akune Barreiros, Juliana Themudo Lessa Mazzucchelli, Sonia Marchezi Hadachi, Laura Maria de Figueiredo Ferreira Guilhoto, Ana Lúcia Acquesta, Isabel Rugue Genov, Silvia Maia Holanda, Regina Sumiko Watanabe Di Gesu, Ana Lucia Goulart, Amélia Miyashiro Nunes dos Santos, Newton Bellesi, Beatriz Tavares Costa‐Carvalho, Antonio Condino‐Neto
Format: Article
Language:Portuguese
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 380
container_issue 4
container_start_page 374
container_title Jornal de Pediatria (Versão em Português)
container_volume 92
creator Marilia Pyles Patto Kanegae
Lucila Akune Barreiros
Juliana Themudo Lessa Mazzucchelli
Sonia Marchezi Hadachi
Laura Maria de Figueiredo Ferreira Guilhoto
Ana Lúcia Acquesta
Isabel Rugue Genov
Silvia Maia Holanda
Regina Sumiko Watanabe Di Gesu
Ana Lucia Goulart
Amélia Miyashiro Nunes dos Santos
Newton Bellesi
Beatriz Tavares Costa‐Carvalho
Antonio Condino‐Neto
description Objective: To apply, in Brazil, the T‐cell receptor excision circles (TRECs) quantification technique using real‐time PCR in newborn screening for severe combined immunodeficiency (SCID) and assess the feasibility of implementing it on a large scale in Brazil. Methods: 8715 newborn blood samples were collected on paper filter and, after DNA elution, TRECs were quantified by real‐time PCR. The cutoff value to determine whether a sample was abnormal was determined by ROC curve analysis, using SSPS. Results: The concentration of TRECs in 8682 samples ranged from 2 to 2181 TRECs/μL of blood, with mean and median of 324 and 259 TRECs/μL, respectively. Forty‐nine (0.56%) samples were below the cutoff (30 TRECs/μL) and were reanalyzed. Four (0.05%) samples had abnormal results (between 16 and 29 TRECs/μL). Samples from patients previously identified as having SCID or DiGeorge syndrome were used to validate the assay and all of them showed TRECs below the cutoff. Preterm infants had lower levels of TRECs than full‐term neonates. The ROC curve showed a cutoff of 26 TRECs/μL, with 100% sensitivity for detecting SCID. Using this value, retest and referral rates were 0.43% (37 samples) and 0.03% (3 samples), respectively. Conclusion: The technique is reliable and can be applied on a large scale after the training of technical teams throughout Brazil
doi_str_mv 10.1016/j.jpedp.2016.05.006
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_faa830e8fa114fd7b2cb4c25162c5bed</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_faa830e8fa114fd7b2cb4c25162c5bed</doaj_id><sourcerecordid>oai_doaj_org_article_faa830e8fa114fd7b2cb4c25162c5bed</sourcerecordid><originalsourceid>FETCH-LOGICAL-d1116-4bcf35774aba49258c6b85273fda4de2828da39e2c273fd34aea0ea37a257db93</originalsourceid><addsrcrecordid>eNpNjMtOwzAUBS0EElXpF7DxDyT4HWdZKh6VKtjAOrq2rytHiVM5Bal8PaiwYHVmZnEIueWs5oybu77uDxgOtfiRmumaMXNBFkJoXWktzeU_viaree4ZY8JqY3WzIOsXnDIcYaCzL4g55T2NU6EzfmJB6qfRpYyBpnH8yFPAmHzC7E80ZXpf4CsNN-QqwjDj6m-X5P3x4W3zXO1en7ab9a4KnHNTKeej1E2jwIFqhbbeOKtFI2MAFVBYYQPIFoU_N6kAgSHIBoRugmvlkmx_f8MEfXcoaYRy6iZI3TlMZd9BOSY_YBcBrGRoI3CuYmic8E55obkRXjsM8hvmolw1</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neonatal screening for severe combined immunodeficiency in Brazil</title><source>ScienceDirect (Online service)</source><creator>Marilia Pyles Patto Kanegae ; Lucila Akune Barreiros ; Juliana Themudo Lessa Mazzucchelli ; Sonia Marchezi Hadachi ; Laura Maria de Figueiredo Ferreira Guilhoto ; Ana Lúcia Acquesta ; Isabel Rugue Genov ; Silvia Maia Holanda ; Regina Sumiko Watanabe Di Gesu ; Ana Lucia Goulart ; Amélia Miyashiro Nunes dos Santos ; Newton Bellesi ; Beatriz Tavares Costa‐Carvalho ; Antonio Condino‐Neto</creator><creatorcontrib>Marilia Pyles Patto Kanegae ; Lucila Akune Barreiros ; Juliana Themudo Lessa Mazzucchelli ; Sonia Marchezi Hadachi ; Laura Maria de Figueiredo Ferreira Guilhoto ; Ana Lúcia Acquesta ; Isabel Rugue Genov ; Silvia Maia Holanda ; Regina Sumiko Watanabe Di Gesu ; Ana Lucia Goulart ; Amélia Miyashiro Nunes dos Santos ; Newton Bellesi ; Beatriz Tavares Costa‐Carvalho ; Antonio Condino‐Neto</creatorcontrib><description>Objective: To apply, in Brazil, the T‐cell receptor excision circles (TRECs) quantification technique using real‐time PCR in newborn screening for severe combined immunodeficiency (SCID) and assess the feasibility of implementing it on a large scale in Brazil. Methods: 8715 newborn blood samples were collected on paper filter and, after DNA elution, TRECs were quantified by real‐time PCR. The cutoff value to determine whether a sample was abnormal was determined by ROC curve analysis, using SSPS. Results: The concentration of TRECs in 8682 samples ranged from 2 to 2181 TRECs/μL of blood, with mean and median of 324 and 259 TRECs/μL, respectively. Forty‐nine (0.56%) samples were below the cutoff (30 TRECs/μL) and were reanalyzed. Four (0.05%) samples had abnormal results (between 16 and 29 TRECs/μL). Samples from patients previously identified as having SCID or DiGeorge syndrome were used to validate the assay and all of them showed TRECs below the cutoff. Preterm infants had lower levels of TRECs than full‐term neonates. The ROC curve showed a cutoff of 26 TRECs/μL, with 100% sensitivity for detecting SCID. Using this value, retest and referral rates were 0.43% (37 samples) and 0.03% (3 samples), respectively. Conclusion: The technique is reliable and can be applied on a large scale after the training of technical teams throughout Brazil</description><identifier>ISSN: 2255-5536</identifier><identifier>EISSN: 2255-5536</identifier><identifier>DOI: 10.1016/j.jpedp.2016.05.006</identifier><language>por</language><publisher>Brazilian Society of Pediatrics</publisher><subject>Combined immunodeficiency ; Neonatal screening ; Primary immunodeficiency ; SCID ; T lymphocytes ; TRECs</subject><ispartof>Jornal de Pediatria (Versão em Português), 2016-07, Vol.92 (4), p.374-380</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Marilia Pyles Patto Kanegae</creatorcontrib><creatorcontrib>Lucila Akune Barreiros</creatorcontrib><creatorcontrib>Juliana Themudo Lessa Mazzucchelli</creatorcontrib><creatorcontrib>Sonia Marchezi Hadachi</creatorcontrib><creatorcontrib>Laura Maria de Figueiredo Ferreira Guilhoto</creatorcontrib><creatorcontrib>Ana Lúcia Acquesta</creatorcontrib><creatorcontrib>Isabel Rugue Genov</creatorcontrib><creatorcontrib>Silvia Maia Holanda</creatorcontrib><creatorcontrib>Regina Sumiko Watanabe Di Gesu</creatorcontrib><creatorcontrib>Ana Lucia Goulart</creatorcontrib><creatorcontrib>Amélia Miyashiro Nunes dos Santos</creatorcontrib><creatorcontrib>Newton Bellesi</creatorcontrib><creatorcontrib>Beatriz Tavares Costa‐Carvalho</creatorcontrib><creatorcontrib>Antonio Condino‐Neto</creatorcontrib><title>Neonatal screening for severe combined immunodeficiency in Brazil</title><title>Jornal de Pediatria (Versão em Português)</title><description>Objective: To apply, in Brazil, the T‐cell receptor excision circles (TRECs) quantification technique using real‐time PCR in newborn screening for severe combined immunodeficiency (SCID) and assess the feasibility of implementing it on a large scale in Brazil. Methods: 8715 newborn blood samples were collected on paper filter and, after DNA elution, TRECs were quantified by real‐time PCR. The cutoff value to determine whether a sample was abnormal was determined by ROC curve analysis, using SSPS. Results: The concentration of TRECs in 8682 samples ranged from 2 to 2181 TRECs/μL of blood, with mean and median of 324 and 259 TRECs/μL, respectively. Forty‐nine (0.56%) samples were below the cutoff (30 TRECs/μL) and were reanalyzed. Four (0.05%) samples had abnormal results (between 16 and 29 TRECs/μL). Samples from patients previously identified as having SCID or DiGeorge syndrome were used to validate the assay and all of them showed TRECs below the cutoff. Preterm infants had lower levels of TRECs than full‐term neonates. The ROC curve showed a cutoff of 26 TRECs/μL, with 100% sensitivity for detecting SCID. Using this value, retest and referral rates were 0.43% (37 samples) and 0.03% (3 samples), respectively. Conclusion: The technique is reliable and can be applied on a large scale after the training of technical teams throughout Brazil</description><subject>Combined immunodeficiency</subject><subject>Neonatal screening</subject><subject>Primary immunodeficiency</subject><subject>SCID</subject><subject>T lymphocytes</subject><subject>TRECs</subject><issn>2255-5536</issn><issn>2255-5536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNjMtOwzAUBS0EElXpF7DxDyT4HWdZKh6VKtjAOrq2rytHiVM5Bal8PaiwYHVmZnEIueWs5oybu77uDxgOtfiRmumaMXNBFkJoXWktzeU_viaree4ZY8JqY3WzIOsXnDIcYaCzL4g55T2NU6EzfmJB6qfRpYyBpnH8yFPAmHzC7E80ZXpf4CsNN-QqwjDj6m-X5P3x4W3zXO1en7ab9a4KnHNTKeej1E2jwIFqhbbeOKtFI2MAFVBYYQPIFoU_N6kAgSHIBoRugmvlkmx_f8MEfXcoaYRy6iZI3TlMZd9BOSY_YBcBrGRoI3CuYmic8E55obkRXjsM8hvmolw1</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Marilia Pyles Patto Kanegae</creator><creator>Lucila Akune Barreiros</creator><creator>Juliana Themudo Lessa Mazzucchelli</creator><creator>Sonia Marchezi Hadachi</creator><creator>Laura Maria de Figueiredo Ferreira Guilhoto</creator><creator>Ana Lúcia Acquesta</creator><creator>Isabel Rugue Genov</creator><creator>Silvia Maia Holanda</creator><creator>Regina Sumiko Watanabe Di Gesu</creator><creator>Ana Lucia Goulart</creator><creator>Amélia Miyashiro Nunes dos Santos</creator><creator>Newton Bellesi</creator><creator>Beatriz Tavares Costa‐Carvalho</creator><creator>Antonio Condino‐Neto</creator><general>Brazilian Society of Pediatrics</general><scope>DOA</scope></search><sort><creationdate>20160701</creationdate><title>Neonatal screening for severe combined immunodeficiency in Brazil</title><author>Marilia Pyles Patto Kanegae ; Lucila Akune Barreiros ; Juliana Themudo Lessa Mazzucchelli ; Sonia Marchezi Hadachi ; Laura Maria de Figueiredo Ferreira Guilhoto ; Ana Lúcia Acquesta ; Isabel Rugue Genov ; Silvia Maia Holanda ; Regina Sumiko Watanabe Di Gesu ; Ana Lucia Goulart ; Amélia Miyashiro Nunes dos Santos ; Newton Bellesi ; Beatriz Tavares Costa‐Carvalho ; Antonio Condino‐Neto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d1116-4bcf35774aba49258c6b85273fda4de2828da39e2c273fd34aea0ea37a257db93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2016</creationdate><topic>Combined immunodeficiency</topic><topic>Neonatal screening</topic><topic>Primary immunodeficiency</topic><topic>SCID</topic><topic>T lymphocytes</topic><topic>TRECs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marilia Pyles Patto Kanegae</creatorcontrib><creatorcontrib>Lucila Akune Barreiros</creatorcontrib><creatorcontrib>Juliana Themudo Lessa Mazzucchelli</creatorcontrib><creatorcontrib>Sonia Marchezi Hadachi</creatorcontrib><creatorcontrib>Laura Maria de Figueiredo Ferreira Guilhoto</creatorcontrib><creatorcontrib>Ana Lúcia Acquesta</creatorcontrib><creatorcontrib>Isabel Rugue Genov</creatorcontrib><creatorcontrib>Silvia Maia Holanda</creatorcontrib><creatorcontrib>Regina Sumiko Watanabe Di Gesu</creatorcontrib><creatorcontrib>Ana Lucia Goulart</creatorcontrib><creatorcontrib>Amélia Miyashiro Nunes dos Santos</creatorcontrib><creatorcontrib>Newton Bellesi</creatorcontrib><creatorcontrib>Beatriz Tavares Costa‐Carvalho</creatorcontrib><creatorcontrib>Antonio Condino‐Neto</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Jornal de Pediatria (Versão em Português)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marilia Pyles Patto Kanegae</au><au>Lucila Akune Barreiros</au><au>Juliana Themudo Lessa Mazzucchelli</au><au>Sonia Marchezi Hadachi</au><au>Laura Maria de Figueiredo Ferreira Guilhoto</au><au>Ana Lúcia Acquesta</au><au>Isabel Rugue Genov</au><au>Silvia Maia Holanda</au><au>Regina Sumiko Watanabe Di Gesu</au><au>Ana Lucia Goulart</au><au>Amélia Miyashiro Nunes dos Santos</au><au>Newton Bellesi</au><au>Beatriz Tavares Costa‐Carvalho</au><au>Antonio Condino‐Neto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonatal screening for severe combined immunodeficiency in Brazil</atitle><jtitle>Jornal de Pediatria (Versão em Português)</jtitle><date>2016-07-01</date><risdate>2016</risdate><volume>92</volume><issue>4</issue><spage>374</spage><epage>380</epage><pages>374-380</pages><issn>2255-5536</issn><eissn>2255-5536</eissn><abstract>Objective: To apply, in Brazil, the T‐cell receptor excision circles (TRECs) quantification technique using real‐time PCR in newborn screening for severe combined immunodeficiency (SCID) and assess the feasibility of implementing it on a large scale in Brazil. Methods: 8715 newborn blood samples were collected on paper filter and, after DNA elution, TRECs were quantified by real‐time PCR. The cutoff value to determine whether a sample was abnormal was determined by ROC curve analysis, using SSPS. Results: The concentration of TRECs in 8682 samples ranged from 2 to 2181 TRECs/μL of blood, with mean and median of 324 and 259 TRECs/μL, respectively. Forty‐nine (0.56%) samples were below the cutoff (30 TRECs/μL) and were reanalyzed. Four (0.05%) samples had abnormal results (between 16 and 29 TRECs/μL). Samples from patients previously identified as having SCID or DiGeorge syndrome were used to validate the assay and all of them showed TRECs below the cutoff. Preterm infants had lower levels of TRECs than full‐term neonates. The ROC curve showed a cutoff of 26 TRECs/μL, with 100% sensitivity for detecting SCID. Using this value, retest and referral rates were 0.43% (37 samples) and 0.03% (3 samples), respectively. Conclusion: The technique is reliable and can be applied on a large scale after the training of technical teams throughout Brazil</abstract><pub>Brazilian Society of Pediatrics</pub><doi>10.1016/j.jpedp.2016.05.006</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2255-5536
ispartof Jornal de Pediatria (Versão em Português), 2016-07, Vol.92 (4), p.374-380
issn 2255-5536
2255-5536
language por
recordid cdi_doaj_primary_oai_doaj_org_article_faa830e8fa114fd7b2cb4c25162c5bed
source ScienceDirect (Online service)
subjects Combined immunodeficiency
Neonatal screening
Primary immunodeficiency
SCID
T lymphocytes
TRECs
title Neonatal screening for severe combined immunodeficiency in Brazil
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A05%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonatal%20screening%20for%20severe%20combined%20immunodeficiency%20in%20Brazil&rft.jtitle=Jornal%20de%20Pediatria%20(Versa%CC%83o%20em%20Portugue%CC%82s)&rft.au=Marilia%20Pyles%20Patto%20Kanegae&rft.date=2016-07-01&rft.volume=92&rft.issue=4&rft.spage=374&rft.epage=380&rft.pages=374-380&rft.issn=2255-5536&rft.eissn=2255-5536&rft_id=info:doi/10.1016/j.jpedp.2016.05.006&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_faa830e8fa114fd7b2cb4c25162c5bed%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d1116-4bcf35774aba49258c6b85273fda4de2828da39e2c273fd34aea0ea37a257db93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true